Trials Determined to be Unavailable

The trials listed on this page have been determined to be “unavailable”. The YODA Project periodically reevaluates trials that are unavailable at the time of inquiry for the following reasons:

  • Trial is ongoing or was completed <18 months ago
  • Regulatory approval is not yet received

If reevaluation identifies that a trial can be made available, the original requestor(s) are contacted. A list of reevaluated trials that are now available to request can also be found on this page.

Unavailable trials

NCT# Generic or Product Name Number of Inquiries Received Reason Trial is Not Available
NCT02670395 N/A 1 Trial is phase 1
NCT01274507 N/A 1 Trial is phase 1
NCT03085108 N/A 1 Trial is phase 1
NCT03180853 N/A 1 Trial ongoing/completed <18 months ago
NCT04080752 N/A 1 Trial ongoing/completed <18 months ago
NCT04644770 N/A 1 Trial ongoing/completed <18 months ago
NCT02663193 Abiraterone Acetate 1 Trial is out of scope (i.e., observational, etc.)
NCT04447040 Acetaminophen 1 Trial ongoing/completed <18 months ago
NCT02564523 Ad26.ZEBOV 1 Regulatory approval not yet received
NCT04436276 Ad26.COV2.S 1 Trial ongoing/completed <18 months ago
NCT04505722 Ad26.COV2.S 5 Trial ongoing/completed <18 months ago
NCT04614948 Ad26.COV2.S 2 Trial ongoing/completed <18 months ago
NCT04765384 Ad26.COV2.S 1 Trial ongoing/completed <18 months ago
NCT02788045 Ad26.Mos.HIV 1 Trial ongoing/completed <18 months ago
NCT03795441 Ad26.RSV.preF 1 Trial is phase 1
NCT02315703 Adenovirus Serotype 26 1 Trial ongoing/completed <18 months ago
NCT04908683 Adenovirus Serotype 26 1 Trial ongoing/completed <18 months ago
NCT04538664 Amivantamab 1 Trial ongoing/completed <18 months ago
NCT02609776 Amivantamab 5 Trial ongoing/completed <18 months ago
NCT03559192 Aticaprant 1 Regulatory approval not yet received
NCT01254773 Bapineuzumab 1 Data cannot be converted to electronic format
NCT01284387 Bapineuzumab 1 Data cannot be converted to electronic format
NCT02354014 Bedaquiline 1 Trial ongoing/completed <18 months ago
NCT04988308 Bermekimab 1 Trial ongoing/completed <18 months ago
NCT04171518 CAST-102-SYST 1 Trial ongoing/completed <18 months ago
NCT01704040 CNTO3157 1 Trial is phase 1
JNS001-JPN03 Concerta 1 Trial materials not available in English
NCT03201965 Daratumumab 1 Trial ongoing/completed <18 months ago
NCT03652064 Daratumumab 1 Trial ongoing/completed <18 months ago
NCT03320707 Daratumumab   1 Trial ongoing/completed <18 months ago
NCT01998971 DARZALEX 2 Trial ongoing/completed <18 months ago
NCT02076009 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02195479 DARZALEX 3 Trial ongoing/completed <18 months ago
NCT02316106 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02477891 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02852837 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02874742 DARZALEX 2 Trial ongoing/completed <18 months ago
NCT03217812 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT03277105 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT03652064 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT03901963 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02195479 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT01998971 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT03412565 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT05250973 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT03896061 ECHELON FLEX GST 1 Trial is out of scope (i.e., observational, etc.)
NCT00799864 EDURANT®   1 Trial ongoing/completed <18 months ago
NCT00086684 ELMIRON® 1 Data Partner alliance member has not agreed to share
NCT00236990 ELMIRON® 1 Data Partner alliance member has not agreed to share
NCT02365597 Erdafitinib 1 Trial ongoing/completed <18 months ago
NCT03390504 Erdafitinib 1 Trial ongoing/completed <18 months ago
NCT04083976 Erdafitinib 1 Trial ongoing/completed <18 months ago
NCT05316155
Erdafitinib 1 Trial is phase 1
NCT01946204 ERLEADA 3 Trial ongoing/completed <18 months ago
NCT01171898 ERLEADA 1 Regulatory approval not yet received
NCT02489318 ERLEADA 3 Trial ongoing/completed <18 months ago
NCT01780259 Esketamine 1 Trial is phase 1
NCT01998958 Esketamine 1 Regulatory approval not yet received
NCT02345148 Esketamine 1 Trial is phase 1
NCT02417064 Esketamine 1 Regulatory approval not yet received
NCT02418585 Esketamine 1 Regulatory approval not yet received
NCT02422186 Esketamine 2 Regulatory approval not yet received
NCT02418585 Esketamine 2 Regulatory approval not yet received
NCT02493868 Esketamine 1 Regulatory approval not yet received
NCT02497287 Esketamine 2 Regulatory approval not yet received
NCT02682225 Esketamine 1 Trial is phase 1
NCT02857777 Esketamine 1 Trial is phase 1
NCT03039192 Esketamine 1 Regulatory approval not yet received
NCT04338321 Esketamine 1 Trial ongoing/completed <18 months ago
NCT02919579 Esketamine 1 Trial is phase 1
NCT03185819 Esketamine 1 Trial ongoing/completed <18 months ago
NCT04599855 Esketamine 1 Trial ongoing/completed <18 months ago
NCT04899336 ExPEC9V 1 Trial ongoing/completed <18 months ago
NCT01964651 FAAH inhibitor 1 Trial is phase 1
NCT01008553 Fentanyl 1 Trial materials not available in English
NCT01008618 Fentanyl 1 Trial materials not available in English
NCT01703481 FGFR kinase inhibitor 1 Trial is ongoing/completed <18 months ago
NCT02301234 Fulranumab 1 Trial ongoing/completed <18 months ago
NCT03298542 Golimumab 1 Trial ongoing/completed <18 months ago
NCT00925574 Guselkumab 1 Trial is phase 1
NCT01484587 Guselkumab 1 Trial is phase 1
NCT01866007 Guselkumab 2 Trial is phase 1
NCT02155192 Guselkumab 1 Trial is phase 1
NCT03090100 Guselkumab 1 Regulatory approval not yet received
NCT03466411 Guselkumab 1 Trial ongoing/completed <18 months ago
NCT03998683 Guselkumab 1 Trial ongoing/completed <18 months ago
NCT01109069  IMBRUVICA 1 Data Partner alliance member has not agreed to share
NCT01578707 IMBRUVICA 1 Regulatory approval not yet received
NCT01599949  IMBRUVICA 1 Data Partner alliance member has not agreed to share
NCT01611090  IMBRUVICA 1 Data Partner alliance member has not agreed to share
NCT01646021 IMBRUVICA 1 Regulatory approval not yet received
NCT01704963 IMBRUVICA 1 Regulatory approval not yet received
NCT01779791  IMBRUVICA 1 Data Partner alliance member has not agreed to share
NCT01855750 IMBRUVICA 2 Trial ongoing/completed <18 months ago
NCT01973387  IMBRUVICA 1 Data Partner alliance member has not agreed to share
NCT01980628 IMBRUVICA 2 Regulatory approval not yet received
NCT01744691 IMBRUVICA 1 Regulatory approval not yet received
NCT01325701 IMBRUVICA 1 Regulatory approval not yet received
NCT02165397 IMBRUVICA 1 Regulatory approval not yet received
NCT02910583 IMBRUVICA 1 Trial ongoing/completed <18 months ago
NCT01243073 Imetelstat 1 Regulatory approval not yet received
NCT01731951 Imetelstat 1 Trial ongoing/completed <18 months ago
NCT02426086 Imetelstat 1 Trial ongoing/completed <18 months ago
NCT02598661 Imetelstat 2 Trial ongoing/completed <18 months ago
NCT05574959 Intraocular lens 1 Trial ongoing/completed <18 months ago
NCT00758030 INVEGA® 1 Trial is phase 1
NCT00791349 INVEGA® 1 Trial is phase 1
NCT00791622 INVEGA® 1 Trial is phase 1
NCT03345342 INVEGA® 1 Trial ongoing/completed <18 months ago
N/A (sponsor ID: R092670-JPN-4) INVEGA® SUSTENNA® 1 Trial materials not available in English
NCT01559272 INVEGA® SUSTENNA® 1 Trial ongoing/completed <18 months ago
NCT02065791 INVOKANA® 1 Trial ongoing/completed <18 months ago
NCT04252287 INVOKANA® 1 Trial ongoing/completed <18 months ago
NCT02609776 JNJ-61186372 1 Trial ongoing/completed <18 months ago
NCT02715011 JNJ-63709178 1 Trial ongoing/completed <18 months ago
NCT02908906 JNJ-63723283 1 Trial ongoing/completed <18 months ago
NCT03915379 JNJ-67571244 1 Trial ongoing/completed <18 months ago
NCT04181827  Ciltacabtagene autoleucel 4 Trial ongoing/completed <18 months ago
NCT03891524 JNJ-70033093 1 Trial ongoing/completed <18 months ago
NCT04811560 JNJ-75276617 1 Trial ongoing/completed <18 months ago
NCT05441501 JNJ-80038114 1 Trial ongoing/completed <18 months ago
NCT02094365 Lumicitabine 1 Regulatory approval not yet received
NCT04577833 Niraparib 1 Trial ongoing/completed <18 months ago
NCT00396565 PALIPERIDONE® 2 Trial materials not available in English
NCT01561898 PALIPERIDONE® 1 Trial materials not available in English
NCT01006265 Ponesimod 1 Regulatory approval not yet received
NCT00855335 PREZISTA® 1 Trial ongoing/completed <18 months ago
NCT01619527 PREZISTA® 1 Trial is phase 1
N/A (sponsor ID: TMC114-C105) PREZISTA® 1 Trial is phase 1
N/A (sponsor ID: TMC114-C114) PREZISTA® 2 Trial is phase 1
N/A (sponsor ID: TMC114-C116) PREZISTA® 1 Trial is phase 1
N/A (sponsor ID: TMC114-C143) PREZISTA® 1 Trial is phase 1
N/A (sponsor ID: TMC114IFD1001) PREZISTA® 1 Trial is phase 1
NCT00814801 RAZADYNE® 2 Trial materials not available in English
N/A
(sponsor ID: GAL-JPN-3)
RAZADYNE® 1 Trial materials not available in English
N/A (sponsor ID: GAL-PED-1001 (CR010954)) RAZADYNE® 1 Trial is out of scope (i.e., observational, etc.)
N/A (sponsor ID: RIS-BEL-24) RISPERDAL® 1 Regulatory approval not yet received
N/A (sponsor ID: RIS-INT-26) RISPERDAL® 1 Data cannot be converted to electronic format
NCT00253110 (sponsor ID: RIS-USA-79) RISPERDAL® 1 Data cannot be converted to electronic format
NCT00240708 (sponsor ID: RIS-JPN-S31) RISPERDAL® 1 Data cannot be converted to electronic format
N/A (sponsor ID: RIS-INT-39) RISPERDAL® 1 Regulatory approval not yet received
N/A (sponsor ID: RIS-NED-9) RISPERDAL® 1 Regulatory approval not yet received
NCT00246194 RISPERDAL CONSTA® 1 Trial is phase 1
NCT00330551 RISPERDAL CONSTA® 1 Trial is phase 1
NCT04988295 Rybrevant 1 Trial ongoing/completed <18 months ago
NCT03374475 Seltorexant 1 Trial ongoing/completed <18 months ago
NCT04513912 Seltorexant 1 Trial ongoing/completed <18 months ago
NCT04116736 senofilcon A 1 Trial ongoing/completed <18 months ago
NCT00727987 SIMPONI 1 Data Partner alliance member has not agreed to share
NCT00771251 SIMPONI 1 Data Partner alliance member has not agreed to share
NCT04816513 STELARA 1 Trial is phase 1
NCT03981744 STELARA 1 Trial ongoing/completed <18 months ago
NCT04075591 STAR S4 IR® Excimer laser System 1 Trial is ongoing/completed <18 months ago
NCT03399799 TALVEY 1 Trial is ongoing/completed <18 months ago
NCT04640623 TAR-200 1 Trial is ongoing/completed <18 months ago
NCT03145181 TECLISTAMAB 2 Trial is phase 1
NCT04557098 TECLISTAMAB 2 Trial is ongoing/completed <18 months ago
NCT05991960 TECNIS Odyssey IOL 1 Trial is ongoing/completed <18 months ago
NCT02359890 THERMOCOOL® SMARTTOUCH® (RF ablation treatment) 1 Trial ongoing/completed <18 months ago
NCT00236496 TOPAMAX 1 Data cannot be converted to electronic format
NCT00236691 TOPAMAX 1 Data cannot be converted to electronic format
NCT00266591 TOPAMAX 1 Data cannot be converted to electronic format
NCT00236743 TOPAMAX 1 Data cannot be converted to electronic format
NCT00236717 TOPAMAX 1 Data cannot be converted to electronic format
NCT01081795 TOPAMAX 2 Trial materials not available in English
NCT01112267 Tramadol HCl 1 Data cannot be converted to electronic format
NCT02207231 TREMFYA® 1 Trial ongoing/completed <18 months ago
NCT02207244 TREMFYA® 1 Trial ongoing/completed <18 months ago
NCT02641730 TREMFYA® 1 Regulatory approval not yet received
NCT03628924 TREMFYA® 1 Trial ongoing/completed <18 months ago
NCT04882098 TREMFYA® 1 Trial ongoing/completed <18 months ago
NCT04147338 TREMFYA® 1 Trial is phase 1
NCT03818035 TREMFYA® 1 Trial ongoing/completed <18 months ago
NCT05299606 Transbronchial Microwave Ablation 1 Trial ongoing/completed <18 months ago
N/A (sponsor ID: TRAM-PEDS-001) ULTRAM ® and ULTRAM® ER 1 Trial is phase 1
N/A (sponsor ID: TRAM-PEDS-005) ULTRAM® and ULTRAM® ER 1 Trial is phase 1
N/A (sponsor ID: TRAM-PEDS-006) ULTRAM® and ULTRAM® ER 1 Trial is phase 1
NCT04266756 UPTRAVI® 1 Trial is phase 1
NCT02627768 Ustekinumab 1 Trial ongoing/completed <18 months ago
NCT00103506 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
NCT00111319 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
NCT00507416 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
NCT00908232 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
NCT00431769 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
PMID: 19036115 VELCADE® 1 Data subject to partner agreement; researcher advised to contact Data Partner
NCT00403767 XARELTO® 8 Data Partner alliance member has not agreed to share
NCT00809965 XARELTO® 1 Data Partner alliance member has not agreed to share and regulatory approval not yet received
NCT00440193 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT00395772 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT00439725 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT00439777 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT00494871 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT01830543 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT01877915 XARELTO® 1 Data Partner alliance member has not agreed to share
NCT02111564 XARELTO® 1 Data Partner alliance member has not agreed to share
N/A Xylometazoline 1 Trial is out of scope (i.e., observational, etc.)
NCT00910754 ZYTIGA® 1 Trial is phase 1
NCT02230046 ZYTIGA® 1 Trial is phase 1
NCT03748641 ZYTIGA® 2 Trial ongoing/completed <18 months ago
Total: 201   Total: 229  

Reevaluated trials that are now available to request:

NCT# Generic or Product Name Number of Inquiries Received Reason Trial was Originally Not Available
NCT00574288 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT01615029 DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02252172 DARZALEX 3 Regulatory approval not yet received
NCT02951819  DARZALEX 1 Trial ongoing/completed <18 months ago
NCT02195869 IMBRUVICA 1 Regulatory approval not yet received
NCT01032629 INVOKANA® 3 Regulatory approval not yet received
NCT01989754 INVOKANA® 3 Regulatory approval not yet received
NCT00488631 SIMPONI® 3 Trial ongoing/completed <18 months ago
NCT00265122 STELARA® 1 Regulatory approval not yet received
NCT00771667 STELARA® 2 Regulatory approval not yet received
NCT01090427 STELARA® 1 Trial ongoing/completed <18 months ago and regulatory approval not yet received
NCT01369329 STELARA® 1 Regulatory approval not yet received
NCT01369342 STELARA® 1 Regulatory approval not yet received
NCT02407236 STELARA® 1 Trial ongoing/completed <18 months ago
NCT01343277 YONDELIS® 1 Trial ongoing/completed <18 months ago
NCT00887198 ZYTIGA® 5 Trial ongoing/completed <18 months ago
NCT01591122 ZYTIGA® 1 Trial ongoing/completed <18 months ago
NCT01715285 ZYTIGA® 6 Trial ongoing/completed <18 months ago
Total: 18   Total: 36  

*Last update: January 1, 2024

Note: Inquiries for trials that were not sponsored by one of the YODA Project’s current partnering Data Partners are not included in either of these lists.